1)厚生労働省:平成14年糖尿病実態調査.厚生労働省,2004
2)Kahn O, Wagner W, Bessman AN:Mortality of diabetic patients treated surgically for lower limb infection and/or gangrene. Diabetes 23:287-292, 1974
3)若林 剛,相川直樹:糖尿病と外科手術.赤沼安夫(編);Common disease series No 1糖尿病―最近の展開.第2版.南江堂,1997,pp99-109
4)葛谷 健,中川昌一,佐藤 譲,他:糖尿病の分類と診断基準に関する委員会報告.糖尿病42:385-404,1999
5)McKenzie CR, Charlson ME:Assessment of perioperative risk in the patient with diabetes mellitus. Surg Gynecol Obstet 167:293-299, 1988
6)高カロリー輸液.日本糖尿病学会(編);糖尿病専門医研修ガイドブック.改訂第2版.診断と治療社,2003,pp243-247
7)炭山嘉伸,草地信也:術後感染症阻止薬の基本的な考え方.消外23:277-281,2000
8)Latham R, Lancaster AD, Convington JF, et al:The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 22:607-612, 2001
9)van den Berghe G, Wouters P, Weekers F, et al:Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367, 2001